4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Euroapi S.A. (EAPI) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Paris, France with about 3,000 employees. Its market capitalization is roughly €93 million. In the fiscal year ended 2025-12-31, EAPI reported €853M in revenue and (€211M) in net income.
Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | €853M | €919M | €1.0B | €981M | — |
| Gross Profit | €145M | €142M | €165M | €177M | — |
| Operating Income (EBIT) | €2M | (€10M) | €4M | €27M | — |
| Net Income | (€211M) | (€131M) | (€190M) | (€15M) | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | €1.3B | €1.5B | €1.6B | €1.7B | — |
| Total Liabilities | €516M | €506M | €685M | €626M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive EAPI viewer.
About TickerBase · Data methodology & sources · Privacy · Terms